NMC

NEA Management Company Portfolio holdings

AUM $1.33B
1-Year Return 85.82%
This Quarter Return
-2.45%
1 Year Return
+85.82%
3 Year Return
+531.37%
5 Year Return
+304.32%
10 Year Return
+4,927.96%
AUM
$1.21B
AUM Growth
-$220M
Cap. Flow
+$121M
Cap. Flow %
10.06%
Top 10 Hldgs %
68.51%
Holding
46
New
2
Increased
3
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

1 Healthcare 88.15%
2 Technology 9.5%
3 Industrials 0.36%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
LQDA icon
26
Liquidia Corp
LQDA
$2.49B
$8.85M 0.73%
2,486,062
CSBR icon
27
Champions Oncology
CSBR
$95.4M
$8.83M 0.73%
1,562,500
DZSI
28
DELISTED
DZS Inc. Common Stock
DZSI
$8.76M 0.73%
956,255
LXRX icon
29
Lexicon Pharmaceuticals
LXRX
$378M
$7.17M 0.59%
2,382,286
RIGL icon
30
Rigel Pharmaceuticals
RIGL
$705M
$6.07M 0.5%
324,315
VRNA
31
Verona Pharma
VRNA
$9.18B
$5.57M 0.46%
1,219,674
XENE icon
32
Xenon Pharmaceuticals
XENE
$2.98B
$5.43M 0.45%
602,663
+419,909
+230% +$3.78M
SURF
33
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$4.71M 0.39%
3,315,149
KA
34
DELISTED
Kineta, Inc. Common Stock
KA
$4.7M 0.39%
39,691
BE icon
35
Bloom Energy
BE
$12.5B
$4.33M 0.36%
1,333,333
XFOR icon
36
X4 Pharmaceuticals
XFOR
$73.9M
$4.24M 0.35%
11,111
TRVN
37
DELISTED
Trevena, Inc.
TRVN
$3.69M 0.31%
6,099
CTIC
38
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$3.14M 0.26%
3,750,000
PHXM
39
DELISTED
PHAXIAM Therapeutics S.A.. American Depositary Shares
PHXM
$2.64M 0.22%
62,500
TCON
40
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$1.55M 0.13%
17,336
RGLS
41
DELISTED
Regulus Therapeutics
RGLS
$1.48M 0.12%
205,246
ELGX
42
DELISTED
Endologix Inc
ELGX
$989K 0.08%
249,021
VIRX
43
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$935K 0.08%
37,094
AKTX
44
Akari Therapeutics
AKTX
$22M
$773K 0.06%
22,608
TRIL
45
DELISTED
Trillium Therapeutics Inc.
TRIL
$646K 0.05%
2,100,000
AKAO
46
DELISTED
Achaogen, Inc.
AKAO
$63K 0.01%
5,215,128